{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:26:18Z","timestamp":1780633578645,"version":"3.54.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Pulmonary invasive aspergillosis is a frequent and life-threatening complication for patients with chronic granulomatous disease (CGD). Despite combined treatment with several groups of antifungal agents, conservative treatment of invasive aspergillosis often remains refractory. Pulmonary invasive aspergillosis is often treated by surgical resection of consolidated lobes or segments, donor granulocyte transfusions and allogeneic hematopoietic stem cell transplantation (HSCT). These options are not mutually exclusive and often combined.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods and Results:<\/jats:title>\n            <jats:p>We here describe the treatment of 3 patients with CGD who received HSCT upon active pulmonary invasive aspergillosis: Two of them received HSCT as salvage therapy for refractory aspergillosis, and 1 patient received elective HSCT in infancy but developed pulmonary aspergillosis during secondary graft failure. Based on our experience and available literature, we discuss indication as well as timing of HSCT, granulocyte transfusions and surgery in patients with CGD and pulmonary invasive aspergillosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Upon diagnosis with invasive aspergillosis in CGD, we propose to start antifungal treatment and preparation for HSCT at the same time. Remission of pulmonary invasive aspergillosis before HSCT remains preferable but is not mandatory. When pulmonary aspergillosis in patients with CGD remains refractory for longer than 3 months on conservative treatment, HSCT without prior surgery or accompanying granulocyte transfusions is a feasible option.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003109","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T18:18:23Z","timestamp":1623089903000},"page":"649-654","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Hematopoietic Stem Cell Transplantation Cures Therapy-refractory Aspergillosis in Chronic Granulomatous Disease"],"prefix":"10.1097","volume":"40","author":[{"given":"Cinzia","family":"Dedieu","sequence":"first","affiliation":[{"name":"Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charit\u00e9 Universit\u00e4tsmedizin"},{"name":"Department of Pediatric Hematology, Oncology and Stem Cell Transplantation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sybille","family":"Landwehr-Kenzel","sequence":"additional","affiliation":[{"name":"Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charit\u00e9 Universit\u00e4tsmedizin"},{"name":"Berlin Institute of Health Center for Regenerative Therapies (BCRT), Charit\u00e9 Universit\u00e4tsmedizin"},{"name":"Berlin Center for Advanced Therapies, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Thee","sequence":"additional","affiliation":[{"name":"Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charit\u00e9 Universit\u00e4tsmedizin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Oevermann","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology, Oncology and Stem Cell Transplantation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Voigt","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology, Oncology and Stem Cell Transplantation"},{"name":"Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Marggraf","sequence":"additional","affiliation":[{"name":"Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charit\u00e9 Universit\u00e4tsmedizin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Schulte","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology, Oncology and Stem Cell Transplantation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Lau","sequence":"additional","affiliation":[{"name":"Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charit\u00e9 Universit\u00e4tsmedizin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Roesler","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rn-Sven","family":"Kuehl","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology, Oncology and Stem Cell Transplantation"},{"name":"Department of Pediatric Oncology, Hematology and Hemostaseology, University of Leipzig, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horst","family":"von Bernuth","sequence":"additional","affiliation":[{"name":"Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charit\u00e9 Universit\u00e4tsmedizin"},{"name":"Berlin Institute of Health Center for Regenerative Therapies (BCRT), Charit\u00e9 Universit\u00e4tsmedizin"},{"name":"Labor Berlin GmbH, Department of Immunology, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,6,7]]},"reference":[{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/jof2020015","article-title":"Aspergillosis in chronic granulomatous disease.","volume":"2","author":"King","year":"2016","journal-title":"J Fungi (Basel)"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3389\/fped.2020.00327","article-title":"Cellular therapies in chronic granulomatous disease.","volume":"8","author":"G\u00fcng\u00f6r","year":"2020","journal-title":"Front Pediatr"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1182\/blood.V92.8.2719","article-title":"Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B.","volume":"92","author":"Ozsahin","year":"1998","journal-title":"Blood"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1056\/NEJM200103223441203","article-title":"Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.","volume":"344","author":"Horwitz","year":"2001","journal-title":"N Engl J Med"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1182\/blood-2002-02-0583","article-title":"Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.","volume":"100","author":"Seger","year":"2002","journal-title":"Blood"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood.2020005590","article-title":"Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults.","volume":"136","author":"Chiesa","year":"2020","journal-title":"Blood"},{"key":"R8-20250615","article-title":"Outcome of chronic granulomatous disease - conventional treatment versus stem cell transplantation [published online ahead of print October 28, 2020].","author":"Dedieu","journal-title":"Pediatr Allergy Immunol"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(13)62069-3","article-title":"Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.","volume":"383","author":"G\u00fcng\u00f6r","year":"2014","journal-title":"Lancet"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood-2016-03-704015","article-title":"Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience.","volume":"128","author":"Morillo-Gutierrez","year":"2016","journal-title":"Blood"},{"key":"R11-20250615","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3389\/fimmu.2017.00937","article-title":"Primary immunodeficiency diseases: current and emerging therapeutics.","volume":"8","author":"Marciano","year":"2017","journal-title":"Front Immunol"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00112-015-3449-x","article-title":"Elektive Stammzelltransplantation bei septischer granulomatose.","volume":"164","author":"Dedieu","year":"2016","journal-title":"Monatsschr Kinderheilkd"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1093\/cid\/cir731","article-title":"Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey.","volume":"53","author":"Blumental","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R14-20250615","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/cid\/ciu1154","article-title":"Common severe infections in chronic granulomatous disease.","volume":"60","author":"Marciano","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12281-013-0168-4","article-title":"Invasive fungal infections in the child with chronic granulomatous disease.","volume":"8","author":"Warris","year":"2014","journal-title":"Curr Fungal Infect Rep"},{"key":"R16-20250615","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1824-7288-40-2","article-title":"Refractory invasive aspergillosis controlled with posaconazole and pulmonary surgery in a patient with chronic granulomatous disease: case report.","volume":"40","author":"Kepenekli","year":"2014","journal-title":"Ital J Pediatr"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4614-4726-9_3","article-title":"Invasive fungal infections in patients with chronic granulomatous disease.","volume":"764","author":"Henriet","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"R18-20250615","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.cmi.2019.05.019","article-title":"ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children.","volume":"25","author":"Warris","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America.","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R20-20250615","doi-asserted-by":"crossref","first-page":"ofaa447","DOI":"10.1093\/ofid\/ofaa447","article-title":"Treatment of chronic granulomatous disease-related pulmonary Aspergillus infection in late pregnancy.","volume":"7","author":"Johnson","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"R21-20250615","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1086\/430068","article-title":"Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection.","volume":"40","author":"Segal","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R22-20250615","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/sj.bmt.1702651","article-title":"Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.","volume":"26","author":"Bielorai","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"R23-20250615","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1097\/01.TP.0000163466.73485.5E","article-title":"Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients.","volume":"79","author":"G\u00fcng\u00f6r","year":"2005","journal-title":"Transplantation"},{"key":"R24-20250615","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/pbc.20865","article-title":"Allogeneic bone marrow transplantation with reduced intensity conditioning for chronic granulomatous disease complicated by invasive Aspergillus infection.","volume":"47","author":"Sastry","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"R25-20250615","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2141.2009.07614.x","article-title":"Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth.","volume":"145","author":"Soncini","year":"2009","journal-title":"Br J Haematol"},{"key":"R26-20250615","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s12185-009-0433-z","article-title":"Treosulfan-based conditioning regimen in a second matched unrelated peripheral blood stem cell transplantation for a pediatric patient with CGD and invasive aspergillosis, who experienced initial graft failure after RIC.","volume":"90","author":"Klaudel-Dreszler","year":"2009","journal-title":"Int J Hematol"},{"key":"R27-20250615","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s10875-011-9513-y","article-title":"Allogeneic haematopoietic stem cell transplantation as therapy for chronic granulomatous disease\u2013single centre experience.","volume":"31","author":"Go\u017adzik","year":"2011","journal-title":"J Clin Immunol"},{"key":"R28-20250615","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s12185-011-0932-6","article-title":"Successful allogeneic hematopoietic stem cell transplantation for chronic granulomatous disease with inflammatory complications and severe infection.","volume":"94","author":"Kato","year":"2011","journal-title":"Int J Hematol"},{"key":"R29-20250615","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaci.2011.10.005","article-title":"Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease.","volume":"129","author":"Martinez","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"R30-20250615","first-page":"1087","article-title":"Chronic granulomatous disease-haematopoietic stem cell transplantation versus conventional treatment.","volume":"102","author":"\u00c5hlin","year":"2013","journal-title":"Acta Paediatr"},{"key":"R31-20250615","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/trf.12325","article-title":"Successful cord blood transplantation after repeated transfusions of unmobilized neutrophils in addition to antifungal treatment in an infant with chronic granulomatous disease complicated by invasive pulmonary aspergillosis.","volume":"54","author":"Shigemura","year":"2014","journal-title":"Transfusion"},{"key":"R32-20250615","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s10875-017-0422-6","article-title":"Allogeneic reduced-intensity hematopoietic stem cell transplantation for chronic granulomatous disease: a Single-Center Prospective Trial.","volume":"37","author":"Parta","year":"2017","journal-title":"J Clin Immunol"},{"key":"R34-20250615","first-page":"277","article-title":"Surgery and granulocyte transfusions for life-threatening infections in chronic granulomatous disease.","volume":"40","author":"Fanconi","year":"1985","journal-title":"Helv Paediatr Acta"},{"key":"R33-20250615","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2017.02.026","article-title":"Granulocyte transfusions in patients with chronic granulomatous disease and refractory infections: the NIH experience.","volume":"140","author":"Marciano","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"R35-20250615","first-page":"71","article-title":"Combined treatment with amphotericin-B and granulocyte transfusion from G-CSF-stimulated donors in an aplastic patient with invasive aspergillosis undergoing bone marrow transplantation.","volume":"82","author":"Catalano","year":"1997","journal-title":"Haematologica"},{"key":"R36-20250615","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1537-2995.2010.02993.x","article-title":"The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort.","volume":"51","author":"Heim","year":"2011","journal-title":"Transfusion"},{"key":"R37-20250615","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/QCO.0b013e328358b0a4","article-title":"Invasive fungal infection in chronic granulomatous disease: insights into pathogenesis and management.","volume":"25","author":"Falcone","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"R38-20250615","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/bmt.2014.125","article-title":"Successful HLA haploidentical hematopoietic SCT in chronic granulomatous disease.","volume":"49","author":"Hoenig","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"R39-20250615","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1038\/s41409-020-0864-y","article-title":"Allogeneic hematopoietic stem cell transplantation using unrelated cord blood or unmanipulated haploidentical donors is effective in pediatric chronic granulomatous disease with inflammatory complications and severe infection.","volume":"55","author":"Tang","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"R40-20250615","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10875-020-00772-z","article-title":"Failure to prevent severe graft-versus-host disease in haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in chronic granulomatous disease.","volume":"40","author":"Parta","year":"2020","journal-title":"J Clin Immunol"},{"key":"R41-20250615","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41591-019-0735-5","article-title":"Lentiviral gene therapy for X-linked chronic granulomatous disease.","volume":"26","author":"Kohn","year":"2020","journal-title":"Nat Med"},{"key":"R42-20250615","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1182\/blood.2019000021","article-title":"Two decades of excellent transplant survival for chronic granulomatous disease: a supraregional immunology transplant center report.","volume":"133","author":"Lum","year":"2019","journal-title":"Blood"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:02:39Z","timestamp":1750003359000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003109","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,7]]}}}